Is ADVM or RYLD a better dividend investment in 2026?

ADVM currently yields 45.87% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: ADVM offers higher current income.

What is the dividend yield difference between ADVM and RYLD?

ADVM has a forward dividend yield of 45.87% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 33.48 percentage points.

Home › Compare › ADVM vs RYLD

ADVM vs RYLD: Dividend Comparison 2026

ADVM yields 45.87% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ADVM wins by $272.4K in total portfolio value

INVESTMENT

TIME HORIZON10 years

ADVM

● Live price

45.87%

Share price

$4.36

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$317.6K

Annual income

$60,065.20

Full ADVM calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — ADVM vs RYLD

📍 ADVM pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ADVM	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ADVM + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ADVM pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ADVM

Annual income on $10K today (after 15% tax)

$3,899.08/yr

After 10yr DRIP, annual income (after tax)

$51,055.42/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, ADVM beats the other by $48,774.89/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ADVM + RYLD for your $10,000?

ADVM: 50%RYLD: 50%

100% RYLD50/50100% ADVM

Portfolio after 10yr

$181.5K

Annual income

$31,374.09/yr

Blended yield

17.29%

📊

Analyst Conviction Gap

Where Wall Street is split right now

ADVM

No analyst data

Price Target

$4.83

+10.8% upside vs current

Range: $4.00 — $5.50

Altman Z

-32.7

Piotroski

1/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ADVM buys

RYLD buys

No recent congressional trades found for ADVM or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricADVMRYLD

Forward yield	45.87% ✓	12.39%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$317.6K ✓	$45.3K
Annual income after 10y	$60,065.20 ✓	$2,682.98
Total dividends collected	$248.2K ✓	$19.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ADVM vs RYLD ($10,000, DRIP)

Year	ADVM Portfolio	ADVM Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$15,287	$4,587.16	$11,939	$1,239.34	+$3.3K → ADVM
2	$22,911	$6,553.70	$14,158	$1,382.89	+$8.8K → ADVM
3	$33,694	$9,179.50	$16,682	$1,532.59	+$17.0K → ADVM
4	$48,670	$12,616.75	$19,537	$1,687.64	+$29.1K → ADVM
5	$69,108	$17,032.01	$22,752	$1,847.20	+$46.4K → ADVM
6	$96,549	$22,602.46	$26,355	$2,010.43	+$70.2K → ADVM
7	$132,818	$29,511.17	$30,376	$2,176.45	+$102.4K → ADVM
8	$180,057	$37,941.48	$34,847	$2,344.43	+$145.2K → ADVM
9	$240,732	$48,070.97	$39,800	$2,513.54	+$200.9K → ADVM
10	$317,648	$60,065.20	$45,269	$2,682.98	+$272.4K → ADVM

ADVM vs RYLD: Complete Analysis 2026

ADVM — Stock

Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; Cornell University; GenSight; Lexeo; and Virovek. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

Full ADVM Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this ADVM vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ADVM vs SCHD ADVM vs JEPI ADVM vs O ADVM vs KO ADVM vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.